Target intelligence / Profile preview

Heparin-binding cytokines and chemokines

Molecular classification
Cytokine, Chemokine, Heparin-binding protein, Growth factor
01

Overview

Heparin-binding cytokines and chemokines represent a broad functional class of signaling proteins characterized by their high affinity for heparin and heparan sulfate proteoglycans (HSPGs) located on cell surfaces and within the extracellular matrix. This interaction is mediated by specific basic amino acid motifs that bind to the acidic sulfate groups of glycosaminoglycans, a process essential for the formation of stable chemotactic gradients and the protection of these proteins from proteolytic degradation. Furthermore, HSPGs often act as co-receptors, facilitating the presentation of these cytokines to their high-affinity signaling receptors to initiate biological responses such as cell migration, proliferation, and angiogenesis. In various diseases, including chronic inflammation, cancer, and transplant rejection, the dysregulation of these heparin-binding mediators drives pathological processes like excessive leukocyte recruitment and tumor vascularization. Therapeutic strategies targeting this class often utilize heparin-mimetics or non-anticoagulant heparinoids to sequester these molecules or displace them from their physiological niches, thereby modulating the immune response and inhibiting disease progression.

Other names
Heparin-binding proteinsGAG-binding cytokinesHeparin-binding growth factorsHeparin-binding inflammatory mediators
02

Mechanism of action

Competitive inhibition of glycosaminoglycan (GAG) binding, sequestration of ligands, displacement from the extracellular matrix, and inhibition of co-receptor-mediated signaling.

03

Biological functions

Signal transductionImmune responseCell migrationAngiogenesisCell proliferationChemotaxisExtracellular matrix sequestration
04

Disease associations

InflammationCancerCardiovascular diseaseInfectionTransplant rejectionWound healingSepsis
05

Safety considerations

Risk of bleeding (anticoagulant effects)Heparin-induced thrombocytopenia (HIT)Broad-spectrum off-target effectsImpaired wound healingPotential for systemic immunosuppression
06

Interacting drugs

Heparin

7 more in the full profile.

07

Biomarkers

Heparin-binding protein (HBP/Azurocidin) levelsPlasma VEGF levelsCXCL12 (SDF-1) expressionSoluble syndecan-1

Beyond the preview

Go deeper on Heparin-binding cytokines and chemokines.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heparin-binding cytokines and chemokines.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call